Cargando…
CCI-007, a novel small molecule with cytotoxic activity against infant leukemia with MLL rearrangements
There is an urgent need for the development of less toxic, more selective and targeted therapies for infants with leukemia characterized by translocation of the mixed lineage leukemia (MLL) gene. In this study, we performed a cell-based small molecule library screen on an infant MLL-rearranged (MLL-...
Autores principales: | Somers, Klaartje, Chudakova, Daria A., Middlemiss, Shiloh M.C., Wen, Victoria W., Clifton, Molly, Kwek, Alan, Liu, Bing, Mayoh, Chelsea, Bongers, Angelika, Karsa, Mawar, Pan, Sukey, Cruikshank, Sarah, Scandlyn, Marissa, Hoang, Wendi, Imamura, Toshihiko, Kees, Ursula R., Gudkov, Andrei V., Chernova, Olga B., Haber, Michelle, Norris, Murray D., Henderson, Michelle J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216782/ https://www.ncbi.nlm.nih.gov/pubmed/27317766 http://dx.doi.org/10.18632/oncotarget.10022 |
Ejemplares similares
-
A novel small molecule that kills a subset of MLL-rearranged leukemia cells by inducing mitochondrial dysfunction
por: Somers, Klaartje, et al.
Publicado: (2019) -
Direct targeted therapy for MLL‐fusion‐driven high‐risk acute leukaemias
por: Cantilena, Sandra, et al.
Publicado: (2022) -
Systematic In Vitro Evaluation of a Library of Approved and Pharmacologically Active Compounds for the Identification of Novel Candidate Drugs for KMT2A-Rearranged Leukemia
por: Karsa, Mawar, et al.
Publicado: (2022) -
The Combination of Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Delays KMT2A-Rearranged Leukemia Progression
por: Xiao, Lin, et al.
Publicado: (2022) -
Working arrangements of the CCI computer exploitation section:
por: Madsen, Jan H B, et al.
Publicado: (1974)